1.
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
by Abou-Alfa, Ghassan K
The lancet oncology, 2020-05, Vol.21 (5), p.671-684

2.
FGF21 regulates metabolism and circadian behavior by acting on the nervous system
by Bookout, Angie L
Nature medicine, 2013-09, Vol.19 (9), p.1147-1152

3.
The role of fibroblast growth factors and their receptors in gliomas: the mutations involved
by Georgiou, Vasiliki
Reviews in the neurosciences, 2019-07-26, Vol.30 (5), p.543-554

4.
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
by WOLTJEN, Knut
Nature, 2009, Vol.458 (7239), p.766-770

5.
From Cradle to Grave: The Multiple Roles of Fibroblast Growth Factors in Neural Development
by Guillemot, François
Neuron (Cambridge, Mass.), 2011-08-25, Vol.71 (4), p.574-588

6.
Role of FGFRL1 and other FGF signaling proteins in early kidney development
by Trueb, Beat
Cellular and molecular life sciences : CMLS, 2013-07, Vol.70 (14), p.2505-2518

7.
Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning
by Martin, Gail R
Nature, 2008-05-15, Vol.453 (7193), p.401-405

8.
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
by Tovar, Victoria Victoria
Gut, 2015-12-11, Vol.66 (3), p.530-540

9.
Klotho converts canonical FGF receptor into a specific receptor for FGF23
by Fukumoto, Seiji
Nature, 2006-12-07, Vol.444 (7120), p.770-774

10.
Achondroplasia
by Horton, William A, Prof
The Lancet (British edition), 2007, Vol.370 (9582), p.162-172

11.
The adventitia: essential regulator of vascular wall structure and function
by Stenmark, Kurt R
Annual review of physiology, 2013, Vol.75 (1), p.23-47

12.
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
by Ishikawa, Hiroki
Nature (London), 2009-10-08, Vol.461 (7265), p.788-792

13.
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets
by Jia, Dongyu
Cancer letters, 2016, Vol.382 (2), p.203-214

14.
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
by Staiger, Harald
Endocrine reviews, 2017-10, Vol.38 (5), p.468-488

15.
Fibroblasts and wound healing: an update
by des Jardins-Park, Heather E
Regenerative medicine, 2018-07-01, Vol.13 (5), p.491-495

16.
Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion
by Yu, Shengqiang
Medical oncology (Northwood, London, England), 2013-08-08, Vol.30 (3), p.674-674

17.
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
by Yamanaka, Shinya
Nature biotechnology, 2008-01, Vol.26 (1), p.101-106

18.
Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance
by Hale, Clarence
Endocrinology (Philadelphia), 2012-01, Vol.153 (1), p.69-80

19.
Dietary Manipulations That Induce Ketosis Activate the HPA Axis in Male Rats and Mice: A Potential Role for Fibroblast Growth Factor-21
by Ryan, Karen K Karen K
Endocrinology (Philadelphia), 2017-10-25, Vol.159 (1), p.400-413

20.
Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway
by Zhang, Chi
Diabetologia, 2015-06-04, Vol.58 (8), p.1937-1948
